Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Comparison of Short-Axis and Long-Axis Internal Jugular Vein Cannulation for First-Pass Success

8 juli 2026 uppdaterad av: Ahmad, University of Health Sciences Lahore

Comparison Between Short Axis and Long Axis For Cannulation Of Internal Jugular Vein in Terms Of First Pass Success

To compare the frequency of first pass success by short axis versus long axis for cannulation of internal jugular vein.

Studieöversikt

Status

Har inte rekryterat ännu

Betingelser

Intervention / Behandling

Detaljerad beskrivning

This randomized controlled trial aims to compare the effectiveness of short-axis and long-axis ultrasound-guided approaches for cannulation of the internal jugular vein (IJV) in terms of first-pass success. Central venous catheterization is a commonly performed procedure for invasive monitoring and administration of medications and fluids. Ultrasound guidance has improved the safety and success of IJV cannulation compared with traditional landmark-based techniques; however, uncertainty remains regarding the optimal ultrasound imaging approach.

A total of 60 eligible patients undergoing IJV cannulation will be enrolled and randomly allocated into two equal groups. Participants in Group A will undergo ultrasound-guided IJV cannulation using the short-axis approach, while participants in Group B will undergo cannulation using the long-axis approach. All procedures will be performed by the researcher under direct supervision using standardized ultrasound-guided techniques.

The primary objective is to compare the frequency of first-pass success between the two approaches. First-pass success is defined as successful IJV cannulation with a single skin puncture and without needle redirection. Baseline demographic and clinical characteristics will be recorded before the procedure. The findings of this study may help identify the preferred ultrasound-guided technique for maximizing first-pass success during IJV cannulation and potentially reducing procedure-related complications associated with multiple cannulation attempts.

Studietyp

Interventionell

Inskrivning (Beräknad)

10

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studera Kontakt Backup

Studieorter

  • Pakistan
    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • National Hospital and Medical Center
        • Kontakt:

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Nej

Beskrivning

Inclusion Criteria:

  • Age 25-70 years.
  • Either male or female gender.
  • Undergoing cannulation of IJV.

Exclusion Criteria:

  • Patients who will be on hemodialysis therapy through double lumen catheter in IJV, assessed by reviewing previous medical records.
  • Patients who will have history of previous insertion of IJV line, assessed by reviewing previous medical records.
  • Patients with history of neck surgery, assessed by reviewing previous medical records.
  • Uncooperative patient.
  • Platelet count < 50,000/mm3.
  • International normalized ration 3 times upper normal limit (1.1).

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Förebyggande
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Aktiv komparator: Group A (Short-Axis Approach)
In this approach, IJV will be visualized by placing the transducer in a transverse orientation on the patient neck at the level of the cricoid cartilage. The needle will be inserted at 60° to the vertical and will be advanced toward the vein employing gentle aspiration on the attached syringe. Entry to the vein will be confirmed by visualizing indentation of the anterior wall of the vein followed by blood in the syringe and by visualizing the tip of the needle inside the vein. Guide wire will be passed followed by dilator insertion and finally central vein line.
Enhet: Short-Axis Ultrasound-Guided Internal Jugular Vein Cannulation
Internal jugular vein cannulation performed under ultrasound guidance using the short-axis approach. The transducer is placed in a transverse orientation at the level of the cricoid cartilage, allowing visualization of the internal jugular vein and carotid artery during needle insertion.
Aktiv komparator: Group B (Long-Axis Approach)
In this approach, the probe will be centered on the IJV and rotated through 90° in a clockwise direction resulting in long axis image of the vein. The needle insertion point will be directly beneath the most proximal end of the ultrasound probe. The needle will be inserted at 30° to the vertical and will be advanced toward the vein employing gentle aspiration. Entry to the vein will be confirmed by visualizing needle entry into the vein followed by aspiration of blood in the syringe. Guide wire will be inserted followed by dilator insertion and finally central vein line.
Enhet: Long-Axis Ultrasound-Guided Internal Jugular Vein Cannulation
Internal jugular vein cannulation performed under ultrasound guidance using the long-axis approach. The transducer is rotated to obtain a longitudinal view of the internal jugular vein, allowing continuous visualization of the needle during vessel cannulation.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
First-Pass Success Rate of Ultrasound-Guided Internal Jugular Vein Cannulation
Tidsram: Assessed during the cannulation procedure (within 5 minutes of initiation of cannulation).
First-pass success rate of ultrasound-guided internal jugular vein cannulation, defined as successful venous cannulation with a single skin puncture and needle pass.
Assessed during the cannulation procedure (within 5 minutes of initiation of cannulation).

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Total Cannulation Success Rate
Tidsram: Assessed during the procedure (within 15 minutes).
Total cannulation success rate, defined as successful placement of the internal jugular venous catheter.
Assessed during the procedure (within 15 minutes).
Number of Needle Passes Required for Successful Cannulation
Tidsram: Recorded during the procedure.
Total number of needle insertion attempts required to achieve successful ultrasound-guided internal jugular vein cannulation.
Recorded during the procedure.
Incidence of Hematoma Formation at the Cannulation Site
Tidsram: Assessed immediately after the procedure and within 24 hours.
Occurrence of hematoma at the internal jugular vein cannulation site following ultrasound-guided catheter insertion.
Assessed immediately after the procedure and within 24 hours.
Incidence of Posterior Vessel Wall Puncture
Tidsram: Assessed during the procedure.
Occurrence of unintended puncture of the posterior wall of the internal jugular vein during ultrasound-guided cannulation.
Assessed during the procedure.
Incidence of Pneumothorax Following Cannulation
Tidsram: Assessed within 24 hours following cannulation.
Occurrence of pneumothorax associated with ultrasound-guided internal jugular vein cannulation.
Assessed within 24 hours following cannulation.
Overall Procedure-Related Complications
Tidsram: Assessed during the procedure and up to 24 hours after cannulation.
Frequency of procedure-related adverse events, including hematoma, posterior vessel wall puncture, pneumothorax, or other complications occurring during or after ultrasound-guided internal jugular vein cannulation.
Assessed during the procedure and up to 24 hours after cannulation.

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

University of Health Sciences Lahore

Utredare

  • Studiestol: Shahida Khawaja, MBBS, FCPS, National Hospital and Medical Center

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Allmänna publikationer

Användbara länkar

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

1 oktober 2026

Primärt slutförande (Beräknad)

1 april 2027

Avslutad studie (Beräknad)

1 april 2027

Studieregistreringsdatum

Först inskickad

25 juni 2026

Först inskickad som uppfyllde QC-kriterierna

2 juli 2026

Första postat (Faktisk)

9 juli 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

10 juli 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

8 juli 2026

Senast verifierad

1 juli 2026

Mer information

Termer relaterade till denna studie

Nyckelord

Andra studie-ID-nummer

  • 06-10-2023

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera